001     177492
005     20240918112146.0
024 7 _ |a 10.1007/s13187-021-02095-y
|2 doi
024 7 _ |a pmid:34783995
|2 pmid
024 7 _ |a 0885-8195
|2 ISSN
024 7 _ |a 1543-0154
|2 ISSN
024 7 _ |a altmetric:117051465
|2 altmetric
037 _ _ |a DKFZ-2021-02579
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Reifegerste, Doreen
|0 0000-0002-8961-7220
|b 0
245 _ _ |a Understanding the Pathway of Cancer Information Seeking: Cancer Information Services as a Supplement to Information from Other Sources.
260 _ _ |a New York, NY
|c 2023
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1726651289_16238
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:M100# / 2023 Feb;38(1):175-184
520 _ _ |a Cancer information services (CISs) can play an important role within the pathway of cancer information seeking, but so far, this role is not well understood. Callers (n = 6,255) who contacted the largest provider of cancer information in Germany participated in a survey in which they reported their information sources, information level, and needs leading to the call. Persons with prior information from a physician (n = 1,507) were compared to people with prior online information (n = 901) and people with prior information from both sources (n = 2,776). Nearly all callers (96.7%) stated prior sources, while physicians and the Internet were the most frequently reported sources. People, who only talked to a doctor before, are more likely to be a patient and in the disease stages during/after the first treatment or with recurrence than prior Internet users. The two groups do not differ in their prior information level but did differ in their information needs. CISs are an important supplement to other sources, while the information repertoire depends on patients' stages during the cancer journey. Specific characteristics and needs of callers with different prior information sources help to individualize the service of CISs and similar providers.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 7 |a Cancer
|2 Other
650 _ 7 |a Cancer information seeking
|2 Other
650 _ 7 |a Cancer information service
|2 Other
650 _ 7 |a Information sources
|2 Other
650 _ 7 |a Pathway
|2 Other
700 1 _ |a Rosset, Magdalena
|b 1
700 1 _ |a Czerwinski, Fabian
|b 2
700 1 _ |a Baumann, Eva
|b 3
700 1 _ |a Gaisser, Andrea
|0 P:(DE-He78)38f0db60217c60db0f9d1902404286e7
|b 4
|u dkfz
700 1 _ |a Kludt, Evelyn
|0 P:(DE-He78)97db62d89928344d190ad4eb02d961d5
|b 5
|u dkfz
700 1 _ |a Weg-Remers, Susanne
|0 P:(DE-He78)76dcc66f81ef265e1968a39c42318846
|b 6
|e Last author
|u dkfz
773 _ _ |a 10.1007/s13187-021-02095-y
|0 PERI:(DE-600)2049313-7
|n 1
|p 175-184
|t Journal of cancer education
|v 38
|y 2023
|x 1543-0154
909 C O |p VDB
|o oai:inrepo02.dkfz.de:177492
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)38f0db60217c60db0f9d1902404286e7
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)97db62d89928344d190ad4eb02d961d5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)76dcc66f81ef265e1968a39c42318846
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2021-01-30
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-30
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J CANCER EDUC : 2022
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-24
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-24
920 1 _ |0 I:(DE-He78)M100-20160331
|k M100
|l M100 Krebsinformationsdienst
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)M100-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21